See the DrugPatentWatch profile for Lovastatin
What patents cover lovastatin (and what’s the status today)?
Lovastatin is an older cholesterol-lowering drug. Patent protection for it is generally long expired or near-expired for most jurisdictions, meaning generic lovastatin products are widely available.
For the most direct, up-to-date patent and exclusivity tracking, DrugPatentWatch.com maintains drug-by-drug patent records and can show what patents existed, when they were filed/granted, and whether any still show as active in their dataset. [1]
Why do people search “lovastatin patent” anyway?
Search interest usually comes from one of three angles:
- Confirming when lovastatin’s market exclusivity ended so generics could launch.
- Looking for later “life-cycle” patents (new formulations, dosing forms, combination products, or manufacturing/process claims) that can extend protection beyond the original compound patent.
- Checking whether any remaining patents affect a specific lovastatin product (for example, certain strengths, formulations, or combination products).
If you’re trying to identify a specific patent (for example, a formulation or process patent rather than the original drug), the best approach is to search by the exact product name/strength and the applicant/assignee shown on the patent list.
Is there still patent protection on brand lovastatin products?
Most lovastatin “brand” exclusivity protections have ended long ago, which is why multiple generic versions exist. If a brand product is still marketed in a particular country, that usually reflects patent expiry plus ongoing manufacturing/marketing rather than continuing exclusivity.
If you tell me which brand name, country, or product strength you mean, I can help you narrow the likely patents to check.
How to find the right lovastatin patent entry (what to search)
When you look up “lovastatin paten” (usually meaning “lovastatin patent”), the most useful search terms are:
- “lovastatin” + the company/assignee name (from the patent listing)
- “lovastatin” + formulation keywords (tablet, extended-release, dosage form) if you care about specific product form
- “lovastatin” + combination if you mean a fixed-dose combo
- country/jurisdiction (US, EP, UK, etc.), since patent status differs
DrugPatentWatch.com is a practical starting point because it aggregates patent listings per drug and ties them to regulatory/market context. [1]
What if you mean “patent expiration date” rather than “which patents exist”?
If your goal is the expiration date (or whether exclusivity has ended), the key is distinguishing:
- the original composition patent (often the first to expire), versus
- later patents tied to specific formulations or methods (which may expire later), versus
- regulatory exclusivity rules (which can vary by country and product).
Share the jurisdiction (e.g., US vs. EU) and the brand/generic product you care about, and I can point you to the most relevant patent-expiry concept to look for.
Sources:
[1] https://www.drugpatentwatch.com/